References
- Meador KJ, Baker GA, Finnell RH et al. for the NEAD Study Group. In utero antiepileptic drug exposure. Neurology7, 407–412 (2006).
- Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344, 1132–1138 (2001).
- Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. Neuropsychological effects of exposure to anticonvulsant medication. Neurology64, 949–954 (2005).
- Tatum WO. The use of antiepileptic drugs in pregnancy. Expert Rev. Neurother.6(7), 1077–1086 (2006).
- Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64, 961–965 (2005).
- Tatum WO IV, Liporace J, Benbadis SR, Kaplan PW. Updates on the treatment of epilepsy in women. Arch. Int. Med164, 137–145 (2004).
- Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Registry. J. Neurol. Neurosurg. Psychiatry77, 193–198 (2006).